Neuphoria Therapeutics Inc. (NEUP) › RevenueNeuphoria Therapeutics Inc. (NEUP) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2025$15.65M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share